相关实验视频
Updated: Jun 27, 2025
07:01
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
21.1K
EPRS-ATF4-COLI通路轴是形甲状腺癌治疗的潜在目标
Li Mi1, Jiaye Liu1, Yujie Zhang1
1Division of Thyroid Surgery, Department of General Surgery and Laboratory of Thyroid and Parathyroid Disease, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, PR China.
概括
哈洛夫基诺 (HF) 通过向EPRS-ATF4-COLI通路,有效地抑制了亚塑性甲状腺癌 (ATC) 的生长. 这项研究揭示了HF作为攻击性甲状腺癌的潜在治疗剂.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 无塑性甲状腺癌 (ATC) 是一种高度攻击性的癌症,需要新的治疗方法.
- 黄 (HF) 作为抗癌药物表现有前途,但其在ATC中的有效性尚未被探索.
研究的目的:
- 研究HF在ATC中的抗瘤作用和机制.
- 确定ATC治疗的潜在治疗目标.
主要方法:
- 在体外和体内测试 (CCK8,殖民地形成,异种移植,有机体) 评估了HF的疗效.
- 药物亲和度响应目标稳定性 (DARTS),西部斑块和IHC确定了HF目标.
- 生物信息学 (GEPIA,GEO) 和分子分析 (RNA-seq,流细胞计) 阐明了机制.
主要成果:
- 在体内,HF抑制了ATC细胞的增殖和瘤的生长.
- 高频率向谷氨基--tRNA合成酶 (EPRS),诱导氨基酸饥饿并减少I型原 (COLI) 表达.
- 通过抑制EMT和血管新生,HF抑制了转移,并促进了亡.
结论:
- 高频表现出ATC的显著治疗潜力.
- EPRS-ATF4-COLI通路是一个有前途的生物标志物和ATC的治疗点.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K